Lannett (LCIN) Stock Price, News & Analysis

Company Overview

Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Trevose, PA.

Key Stats

• Today's Range: N/A
• 50-Day Range: $0.02 to $0.03
• 52-Week Range: N/A
• Volume: 441,200 shs
• Average Volume: 475,780 shs
• Market Capitalization: $160,000.00
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 11/21/2024
• Fiscal Year End: 6/30/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: N/A
• Current Symbol: NYSE:LCIN
• CUSIP: N/A
• CIK: 57725
• Web: www.lannett.com
• Phone: (215) 333-9000
• Fax: 215-333-9004
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($18.88)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-231,620,000.00
• Net Margins: -62.40%
• Pretax Margin: -62.67%
• Return on Equity: N/A
• Return on Assets: -13.39%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.23
• Quick Ratio: 1.39

Sales & Book Value

• Annual Sales: $340.58 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($23.34) per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 10,490,000
• Free Float: 9,354,000
• Market Cap: $160,000.00
• Optionable: Optionable
• Beta: 0.92